Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
Esophageal Disorders
When do you consider de-escalating therapy such as dupilumab in eosinophilic esophagitis?
Related Questions
Is there evidence that certain PPIs provide superior clinical efficacy compared to others in real-world practice?
In managing esophageal papillomas, under what circumstances is high-risk HPV testing indicated, and is endoscopic surveillance warranted?
How do you diagnose and manage suspected opioid-induced esophageal dysfunction?
Do you prescribe respiratory muscle training (RMT) devices to patients with dysphagia?
How would you approach the management of an incidentally detected subcentimeter nodule located just below/adjacent to the GE junction in a patient without Barrett’s, that is found to harbor high-grade dysplasia (HGD) on pathology following EMR?
In patients on long-term proton pump inhibitors for GERD with stable symptoms, do you routinely attempt discontinuation or continue indefinitely given relapse risk?
How do you approach surveillance and repeat biopsies in a patient with a diagnosis of intestinal metaplasia (aka Barrett's esophagus) on pathology who appears to have a regular Z-line or <1 cm of salmon mucosa?
What therapies would be considered safe and effective in pregnant patients with EoE?
What is your approach to work up and management of a patient with advanced HIV and poor adherence to therapy presenting with dysphagia and fever?
What are the target distensibility index and EGJ diameter values on EndoFLIP following peroral endoscopic myotomy (POEM)?
